Results 91 to 100 of about 1,662 (181)

Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population

Pakistan Journal of Medicine and Dentistry
Background: Pterygium is a progressive fibrovascular tissue that affects the conjunctiva and cornea. The aim of the study was to compare the efficacy of Sub-conjunctival injection of Mitomycin C versus Bevacizumab in pterygium treatment focusing on ...
Amber khalid, Sharjeel Sultan, Aveen Fatima, Ayesha Khalid, Maryam Shifa   +4 more
doaj   +1 more source

Immunohistochemical staining of bevacizumab after subconjunctival injection as detected by a Cy3-conjugated IgG antibody.

, 2014
Time-dependent diffusion of bevacizumab into the corneal stroma was observed. Normal: eyes without induction of corneal NV. Bevacizumab molecule staining was observed in the entire thickness of corneal stroma adjacent to the injection site in all groups ...
Wei-Li Chen (548626), Yan-Ming Chen (548627), Fung-Rong Hu (223287), Lu-Ping Chow (172169), Chung-Tien Lin (548629), Hsiao-Sang Chu (548628), Chih-Ta Chen (548630)   +6 more
core   +1 more source

Delayed recurrent hyphema following trabeculectomy: A case series of swan syndrome managed with anti-VEGF therapy

Indian Journal of Ophthalmology. Case Reports
Swan syndrome refers to delayed recurrent intraocular bleeding caused by vascular ingrowth at the site of a prior surgical wound. Although classically described after cataract surgery, it has rarely been reported following trabeculectomy. We report three
Priyanka Sudhakar, Gowri J Murthy, Praveen R Murthy   +2 more
doaj   +1 more source

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center

Clinical Ophthalmology, 2020
Kyuhwan Jang,1 Jayoung Ahn,1 Joonhong Sohn,1 Daniel Duck-Jin Hwang1,2 1Department of Ophthalmology, HanGil Eye Hospital, Incheon, Korea; 2Department of Ophthalmology, Catholic Kwandong University College of Medicine, Incheon, KoreaCorrespondence: Daniel ...
Jang K, Ahn J, Sohn J, Hwang DDJ
doaj  

Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. [PDF]

J Ocul Pharmacol Ther, 2015
Nava-Castañeda A, Ulloa-Orozco I, Garnica-Hayashi L, Hernandez-Orgaz J, Jimenez-Martinez MC, Garfias Y.   +5 more
europepmc   +1 more source

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab

International Medical Case Reports Journal, 2019
Nandita Anand, James J Reidy, Kamran M RiazDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USAAbstract: We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster ...
Anand N, Reidy JJ, Riaz KM
doaj  

Effects of Subconjunctival Bevacizumab and Ranibizumab on Corneal and Systemic Oxidative Stress Biomarkers in an Alkali Injury Model. [PDF]

Life (Basel)
Yarbağ A, Bardaş Özkan E, Ulaş M, Arslan YK.   +3 more
europepmc   +1 more source

Effect of Bevacizumab on Pterygium: A Case Series Study

Purpose: to study evaluate the effectiveness of a single subconjunctival injection of bevacizumab (Avastin), an anti-vascular endothelial growth factor (VEGF) agent, in reducing pterygium size and vascularization among patients with primary pterygium ...
Alishiri , Aliagha, Hassani , Mahmood, Daryabari, Seyed Hashem   +2 more
core   +1 more source

Systemic and ocular complications related to intravitreal administration of anti-VEGF agents. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Koksaldi S, Kayabasi M, Karti O, Saatci AO.   +3 more
europepmc   +1 more source

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Ranibizumab and Bevacizumab in Rabbit Cornea

Kafkas Universitesi Veteriner Fakultesi Dergisi, 2013
EKINCI M, CAGATAY HH, YAZAR Z, BINGOL SA, KAPLAN A   +4 more
openaire   +2 more sources